Immunohistochemistry studies revealed that FRβ is frequently co-expressed with CD163 in TAM from primary and metastatic melanoma and in the stroma of lung [63], ovary [62], colon, gastric [64], and breast cancers [65], where numerous CD68+ TAM were also present [62] (Table 1). The gene discussed is FOLR2; the disease is breast carcinoma.